Imidazopyridazines as modulators of IL-17

Imidazopyridazines as modulators of IL-17

The present application discloses compounds having the following formula:or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4 and R5 are defined in the specification, as well as methods of making and using the compounds disclosed herein for treating or ameliorating an IL-17 mediated...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Goldberg, Steven, Meduna, Steven P, McCarver, Stefan, Valdes, Alexander, Xue, Xiaohua, Keith, John, Behenna, Douglas, Rhorer, Timothy B, Martin, Connor
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Goldberg, Steven
Meduna, Steven P
McCarver, Stefan
Valdes, Alexander
Xue, Xiaohua
Keith, John
Behenna, Douglas
Rhorer, Timothy B
Martin, Connor
description The present application discloses compounds having the following formula:or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4 and R5 are defined in the specification, as well as methods of making and using the compounds disclosed herein for treating or ameliorating an IL-17 mediated syndrome, disorder and/or disease.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US11702422B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US11702422B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US11702422B23</originalsourceid><addsrcrecordid>eNrjZND0zM1MSazKL6gsAtGZeanFConFCrn5KaU5iSX5RcUK-WkKnj66huY8DKxpiTnFqbxQmptB0c01xNlDN7UgPz61uCAxOTUvtSQ-NNjQ0NzAyMTIyMnImBg1AOYUKEY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Imidazopyridazines as modulators of IL-17</title><source>esp@cenet</source><creator>Goldberg, Steven ; Meduna, Steven P ; McCarver, Stefan ; Valdes, Alexander ; Xue, Xiaohua ; Keith, John ; Behenna, Douglas ; Rhorer, Timothy B ; Martin, Connor</creator><creatorcontrib>Goldberg, Steven ; Meduna, Steven P ; McCarver, Stefan ; Valdes, Alexander ; Xue, Xiaohua ; Keith, John ; Behenna, Douglas ; Rhorer, Timothy B ; Martin, Connor</creatorcontrib><description>The present application discloses compounds having the following formula:or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4 and R5 are defined in the specification, as well as methods of making and using the compounds disclosed herein for treating or ameliorating an IL-17 mediated syndrome, disorder and/or disease.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230718&amp;DB=EPODOC&amp;CC=US&amp;NR=11702422B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230718&amp;DB=EPODOC&amp;CC=US&amp;NR=11702422B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Goldberg, Steven</creatorcontrib><creatorcontrib>Meduna, Steven P</creatorcontrib><creatorcontrib>McCarver, Stefan</creatorcontrib><creatorcontrib>Valdes, Alexander</creatorcontrib><creatorcontrib>Xue, Xiaohua</creatorcontrib><creatorcontrib>Keith, John</creatorcontrib><creatorcontrib>Behenna, Douglas</creatorcontrib><creatorcontrib>Rhorer, Timothy B</creatorcontrib><creatorcontrib>Martin, Connor</creatorcontrib><title>Imidazopyridazines as modulators of IL-17</title><description>The present application discloses compounds having the following formula:or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4 and R5 are defined in the specification, as well as methods of making and using the compounds disclosed herein for treating or ameliorating an IL-17 mediated syndrome, disorder and/or disease.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZND0zM1MSazKL6gsAtGZeanFConFCrn5KaU5iSX5RcUK-WkKnj66huY8DKxpiTnFqbxQmptB0c01xNlDN7UgPz61uCAxOTUvtSQ-NNjQ0NzAyMTIyMnImBg1AOYUKEY</recordid><startdate>20230718</startdate><enddate>20230718</enddate><creator>Goldberg, Steven</creator><creator>Meduna, Steven P</creator><creator>McCarver, Stefan</creator><creator>Valdes, Alexander</creator><creator>Xue, Xiaohua</creator><creator>Keith, John</creator><creator>Behenna, Douglas</creator><creator>Rhorer, Timothy B</creator><creator>Martin, Connor</creator><scope>EVB</scope></search><sort><creationdate>20230718</creationdate><title>Imidazopyridazines as modulators of IL-17</title><author>Goldberg, Steven ; Meduna, Steven P ; McCarver, Stefan ; Valdes, Alexander ; Xue, Xiaohua ; Keith, John ; Behenna, Douglas ; Rhorer, Timothy B ; Martin, Connor</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US11702422B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>Goldberg, Steven</creatorcontrib><creatorcontrib>Meduna, Steven P</creatorcontrib><creatorcontrib>McCarver, Stefan</creatorcontrib><creatorcontrib>Valdes, Alexander</creatorcontrib><creatorcontrib>Xue, Xiaohua</creatorcontrib><creatorcontrib>Keith, John</creatorcontrib><creatorcontrib>Behenna, Douglas</creatorcontrib><creatorcontrib>Rhorer, Timothy B</creatorcontrib><creatorcontrib>Martin, Connor</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Goldberg, Steven</au><au>Meduna, Steven P</au><au>McCarver, Stefan</au><au>Valdes, Alexander</au><au>Xue, Xiaohua</au><au>Keith, John</au><au>Behenna, Douglas</au><au>Rhorer, Timothy B</au><au>Martin, Connor</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Imidazopyridazines as modulators of IL-17</title><date>2023-07-18</date><risdate>2023</risdate><abstract>The present application discloses compounds having the following formula:or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4 and R5 are defined in the specification, as well as methods of making and using the compounds disclosed herein for treating or ameliorating an IL-17 mediated syndrome, disorder and/or disease.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US11702422B2
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
title Imidazopyridazines as modulators of IL-17
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T11%3A29%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Goldberg,%20Steven&rft.date=2023-07-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS11702422B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true